Elixinol Wellness (ASX:EXL) EV-to-EBIT : -0.77 (As of May. 25, 2024)

View and export this data going back to 2018. Start your Free Trial

What is Elixinol Wellness EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Elixinol Wellness's Enterprise Value is A$5.76 Mil. Elixinol Wellness's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was A$-7.44 Mil. Therefore, Elixinol Wellness's EV-to-EBIT for today is -0.77.

The historical rank and industry rank for Elixinol Wellness's EV-to-EBIT or its related term are showing as below:

ASX:EXL' s EV-to-EBIT Range Over the Past 10 Years
Min: -546.07 Med: -0.35 Max: 0.47
Current: -0.77

During the past 6 years, the highest EV-to-EBIT of Elixinol Wellness was 0.47. The lowest was -546.07. And the median was -0.35.

ASX:EXL's EV-to-EBIT is ranked worse than
100% of 672 companies
in the Drug Manufacturers industry
Industry Median: 16.985 vs ASX:EXL: -0.77

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Elixinol Wellness's Enterprise Value for the quarter that ended in Dec. 2023 was A$8.15 Mil. Elixinol Wellness's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was A$-7.44 Mil. Elixinol Wellness's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -91.28%.

Elixinol Wellness EV-to-EBIT Historical Data

The historical data trend for Elixinol Wellness's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elixinol Wellness EV-to-EBIT Chart

Elixinol Wellness Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-EBIT

Get a 7-Day Free Trial

-0.84

-1.17

-0.82

-0.57

-1.10

Elixinol Wellness Semi-Annual Data
	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-EBIT	Get a 7-Day Free Trial							-0.82	-	-0.57	-	-1.10

Competitive Comparison of Elixinol Wellness's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Elixinol Wellness's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Elixinol Wellness's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Elixinol Wellness's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Elixinol Wellness's EV-to-EBIT falls into.

Elixinol Wellness EV-to-EBIT Calculation

Elixinol Wellness's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	5.758	/	-7.436
	=	-0.77

Elixinol Wellness's current Enterprise Value is A$5.76 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Elixinol Wellness's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was A$-7.44 Mil.

Elixinol Wellness (ASX:EXL) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Elixinol Wellness's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 )	=	EBIT	/	Enterprise Value (Q: Dec. 2023 )
	=	-7.436	/	8.146591493
	=	-91.28 %

Elixinol Wellness's Enterprise Value for the quarter that ended in Dec. 2023 was A$8.15 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Elixinol Wellness's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was A$-7.44 Mil.

Elixinol Wellness EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Elixinol Wellness's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Elixinol Wellness (ASX:EXL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Elixinol Wellness Ltd (ASX:EXL) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

ELLXF:USA

Address

680 George Street, Level 12, Sydney, NSW, AUS, 2000

Website

https://www.elixinolwellness.com

Elixinol Wellness Ltd is engaged in the hemp industry, innovating, marketing, and selling hemp-derived nutraceutical, cosmetic, and food products. It operates in the geographical segments of the Americas, Australia, Europe and other regions of which key revenue is derived from the Americas segment. The Americas segment includes the trading results of Elixinol LLC (Elixinol Americas) and its investments and joint ventures in the US through the manufacture and distribution of hemp-derived cannabidiol products.

Elixinol Wellness (ASX:EXL) Headlines

No Headlines